Introduction

According to the Centers for Disease Control and Prevention, nearly one-fifth of adults reported depressive symptoms annually1. Compared to heterosexuals, sexual minorities have higher rates of depression and more likely to manifest symptoms of anxiety possibly related to greater social stigma regarding their sexuality2,3. Additionally, due to biological and external factors, the rates of depression vary based on sex, race, and socioeconomic status4,5. Previous studies indicate that depression is more prevalent among women, racial minorities, and those of lower socioeconomic status5,6,7. However, the intersection of sexual minority groups with respect to these demographic factors has not been thoroughly analyzed. Additionally, demographic intersections have been previously found to impact mental health outcomes. Furthermore, there may be a proportion of patients with depression that can be explained through chronic inflammation8. Previous studies have cited systemic inflammation (measured by CRP levels) due to social stigma and a lack of safety as a possible indicator for poor health outcomes among sexual minorities9. Although systemic inflammation has been shown to be associated with depressive symptoms, this relationship is not clearly defined after adjusting for sex and racial groups4,5. In this project, we compared the rates of depression and inflammation levels with respect to sexual orientation. In addition, we also examined the intersection of demographic and clinical factors with respect to depression rates.

Methods

Data source

Data was collected from the National Health and Nutrition Examination Survey (NHANES) which is publicly available. NHANES is a national survey conducted by the Centers for Disease Control and Prevention that utilizes a combination of in-home interviews and physical examinations to evaluate the health and nutritional status of U.S. residents10. Depressive symptoms and C-reactive protein (CRP) data were available between 2005 and 2010, and then supplemented with data on demographics, healthcare characteristics, and sexual orientation.

Inclusion/exclusion criteria

We elected to include participants aged 20–59 (N = 9404) years since this group responded to sexual behavior and smoking behavior questionnaires. From this we excluded female participants who were pregnant (431). Individuals with missing information on depressive symptoms (20), marital status (7), education (7), body mass index (45) demographic, socioeconomic characteristics, CRP levels (349), self-identified sexual orientation, and depressive-related symptoms (20) were excluded from our analysis. Since prior studies have shown that abnormally high CRP levels have been associated with active infection instead of chronic inflammation, we also excluded those with CRP ≥ 10 mg/dL (7) from our analytic dataset. After incorporating the exclusion criteria our final analytic dataset came out to be 8,538.

Outcomes and measures

Individuals were defined collectively as sexual minority if they self-reported their sexual orientation as either gay, lesbian, or bisexual. Depressive-related symptoms were measured based on the nine-item Patient Health Questionnaire (PHQ-9) using a scoring system ranging from 0 (not at all) to 3 (nearly every day). Participants with a score ≥ 10 indicate depressive symptoms8. CRP, a serum inflammatory biomarker, was analyzed with the Behring Nephelometer using anti-CRP antibody latex particles. Participants’ age was dichotomized using the median value, 40 years. Race was categorized as non-Hispanic white, non-Hispanic black, Hispanic, and another race (includes Asian race, mixed race, and other race). Individual’s level of education in our cohort was grouped as less than high school, high school, and above high school. To define income levels, we used the poverty-income ratio (PIR) which is the ratio of family income to poverty threshold. Using this ratio and the U.S Census definition of income categories, we categorized income levels as poverty (PIR < 1), low income (1.0 ≤ PIR < 2.0), middle income (2.0 ≤ PIR < 4.0), and high income (PIR ≥ 4.0). We elected to combine “poverty” and “low income” groups for our analysis. In our analysis marital status was grouped as “single”, “married or with partner”, “divorced or separated or widowed.” Participants' smoking status was either reported as a current, former, or non-smoker. Based on CDC on defining body mass index (BMI) categories, we categorized this variable as underweight (< 18.5 kg/m2), normal (18.5–24.9 kg/m2), overweight (25.0–29.9 kg/m2), and obese (≥ 30.0 kg/m2).

Data analysis

Using SAS Enterprise Guide Version 7.1 (SAS Institute Inc., Cary, NC, USA), chi-square, t-tests, and multivariate logistic regression were employed for statistical methods. Incorporating cluster, strata, and weighted variables in our analysis accounted for sampling weights and complexity of survey design and ensured that the oversampling of any groups did not occur. Covariates for the multivariable logistic regression model were determined by conducting bi-variable chi-square tests. Variables found to be significantly associated with depressive symptoms were included as a covariate. Associations were considered to be statistically significant if the two-sided P-value is 0.05 or less. NHANES data is publicly available and the datasets used in this study can be found online.

Consent to participate/Consent to publish

This study was deemed exempt from IRB approval as it contains de-identified information.

Human and animal rights

All statistical methods for this NHANES study were conducted in accordance with the Declaration of Helsinki.

Results

Of 8538 participants (median age: 40 years, range: 20–59), heterosexuals comprised 95.8% and 4.2% were sexual minorities. Depressive symptoms were reported in 5.4% of males versus 9.7% of females (P < 0.001) and 7.1% of the heterosexuals versus 15.8% of sexual minorities (P = 0.001) (Table 1). From 2005 to 2010, the sexual minorities with depressive symptoms have increased from 12.7 to 22.3% (P = 0.16) whereas heterosexuals remained stable over time (5.5–7.7%). C-reactive protein was significantly higher in those with depressive symptoms compared to those without depressive symptoms in heterosexuals (0.54 mg/dL vs. 0.35 mg/dL; P < 0.001) and sexual minorities (0.55 mg/dL vs. 0.35 mg/dL; P = 0.13), though statistically insignificant (Table 2). In an intersection analysis of females who are black and sexual minorities, their depressive symptoms were reported at 33.4% compared to only 5% of white heterosexual males (P = 0.001) (Fig. 1), with corresponding CRP levels of 0.52 mg/dL and 0.43 mg/dL (P = 0.01) (Table 3). On multivariate analysis, sexual minorities (OR = 2.05, 95% CI: 1.38–3.04; P = 0.001), females (OR = 1.81, 95% CI: 1.51–2.16; P < 0.001), and those with elevated CRP levels (OR = 1.22, 95% CI: 1.09–1.40; P = 0.001) were independently associated with depressive symptoms (Table 4).

Table 1 Demographics, socioeconomic status, and behavioral characteristics by depressive symptoms.
Table 2 Demographics, socioeconomic status, and behavioral characteristics by depressive symptoms and sexual orientation.
Figure 1
figure 1

Depressive symptoms by sex, race, and sexual minority.

Table 3 Demographics, socioeconomic status, and behavioral characteristics by depressive symptoms and sexual orientation stratified by sex.
Table 4 Adjusted odds ratio of depressive symptoms between 2005 and 2010.

Discussion

Sexual minorities reported more depressive symptoms compared to heterosexuals. Of note, nearly one-third of the female Black sexual minority intersection group had depressive symptoms. Furthermore, sexual minorities with depressive symptoms had significantly higher inflammation expressed by C-reactive protein.

Our results found that sexual minority individuals had more depressive symptoms. Others have also found that depression was significantly higher in LGBT individuals compared to heterosexuals11. This finding supports the minority stress theory, as described by Brooks, which postulates that exposure to discrimination, stigma, and prejudice on the basis of sexual orientation and gender identity negatively impacts sexual minorities12. LGBT individuals may have internalized feelings of homophobia or expectations of rejection that may contribute to their depressive symptoms3.

A previous study showed that Black and Latino same-sex-attracted individuals reported higher rates of depressive symptoms compared to their heterosexual counterparts13. However, this study did not evaluate the intersection of sex, race, and sexual orientation with respects to depression. Our data showed that black female sexual minorities had the highest rates of depressive symptoms. To our knowledge, this is one of the few studies that have evaluated the intersection between sex, race, and sexual orientation.

Our study identified that the intersectional group of black, sexual minority, and female sex had the highest level of C-reactive protein compared to other groups. The intersection of social categorizations including sex, race, and sexual orientation result in overlapping, interdependent systems of advantages or disadvantages. In this report, we showed that black female sexual minorities experience overlapping prejudices that may further increase stress levels14. On the other hand, other investigators have found that sexual minority men had higher levels of C-reactive protein compared to sexual minority women15. Clearly, the role of inflammation warrants further analysis given the multiple biologic and external factors that may confound these results.

Such factors such as sedentary lifestyle, diet, and disordered sleep were not included in our study. Medical illnesses including cancer, autoimmune, inflammatory disorders, and cardiovascular disease are also limited. Additionally, there is much unknown in regard to childhood impact, with factors such as childhood maltreatment and emotional as well as physical trauma.

Conclusion

Female black sexual minorities reported significantly higher depressive symptoms compared to their white heterosexual counterparts. Based on our findings, further studies are warranted to address the reasons behind the disparities in the incidences and treatment of depression in correlation with systemic inflammation biomarkers. Additionally, this study highlights the need for improved social support systems and clinical mental health treatment for these at-risk subgroups.